The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

We have identified a novel series of potent p38 MAP kinase inhibitors through structure-based design which due to their extended molecular architecture bind, in addition to the ATP site, to an allosteric pocket. In vitro ADME and in vivo PK studies show these compounds to have drug-like characteristics which could result in the development of an oral treatment for inflammatory conditions.

Knowledge Graph

Similar Paper

The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Optimization of α-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site
Bioorganic & Medicinal Chemistry Letters 2010.0
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis
Bioorganic & Medicinal Chemistry Letters 2004.0
Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode
Bioorganic & Medicinal Chemistry Letters 2008.0
Targeting the Hinge Glycine Flip and the Activation Loop: Novel Approach to Potent p38α Inhibitors
Journal of Medicinal Chemistry 2012.0
Two classes of p38α MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes
Bioorganic & Medicinal Chemistry Letters 2005.0
Design, Synthesis, and Biological Evaluation of Novel Type I<sup>1</sup>/<sub>2</sub> p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine
Journal of Medicinal Chemistry 2017.0
Potent inhibitors of the MAP kinase p38
Bioorganic &amp; Medicinal Chemistry Letters 1998.0
Design, Synthesis, and Biological Evaluation of Phenylamino-Substituted 6,11-Dihydro-dibenzo[b,e]oxepin-11-ones and Dibenzo[a,d]cycloheptan-5-ones:  Novel p38 MAP Kinase Inhibitors
Journal of Medicinal Chemistry 2006.0
Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity
Journal of Medicinal Chemistry 2013.0